1. The transcription factor XBP1 in dendritic cells promotes the TH2 cell response in airway allergy.
- Author
-
Yang, Gui, Zeng, Xian-Hai, Geng, Xiao-Rui, Liu, Jiang-Qi, Mo, Li-Hua, Luo, Xiang-Qian, Liu, Hua-Zhen, Zhang, Yuan-Yi, Yang, Li-Teng, Huang, Qin-Miao, Xiao, Xiao-Jun, Liu, Jie, Xu, Ling-Zhi, Liu, Da-Bo, Liu, Xiao-Yu, Liu, Zhi-Qiang, and Yang, Ping-Chang
- Subjects
KILLER cell receptors ,DENDRITIC cells ,TRANSCRIPTION factors ,GUANINE nucleotide exchange factors ,CELL receptors ,RAS proteins - Abstract
Dendritic cells (DCs) that express T cell immunoglobulin domain molecule-4 (TIM4), a cell surface receptor for phosphatidylserine, induce T helper 2 (T
H 2) cell responses and allergic reactions. We elucidated the role of the transcription factor X-box–binding protein-1 (XBP1) in the induction of the TH 2 cell response through its role in generating TIM4+ DCs. We found that XBP1 was required for TIM4 mRNA and protein expression in airway DCs in response to the cytokine interleukin-2 (IL-2) and that this pathway was required for TIM4 expression on DCs in response to the allergens PM2.5 and Derf1. The IL-2–XBP1–TIM4 axis in DCs contributed to Derf1/PM2.5-induced, aberrant TH 2 cell responses in vivo. An interaction between the guanine nucleotide exchange factor Son of sevenless-1 (SOS1) and the GTPase RAS promoted XBP1 and TIM4 production in DCs. Targeting the XBP1-TIM4 pathway in DCs prevented or alleviated experimental airway allergy. Together, these data suggest that XBP1 is required for TH 2 cell responses by inducing the development of TIM4+ DCs, which depends on the IL-2–XBP1–SOS1 axis. This signaling pathway provides potential therapeutic targets for the treatment of TH 2 cell–dependent inflammation or allergic diseases. Editor's summary: T helper 2 (TH 2) cells mediate allergic responses, and their development depends on dendritic cells (DCs) expressing the receptor TIM4. Yang et al. found that the transcription factor XBP1 induced expression of the gene encoding TIM4 in DCs. Production of the cytokine IL-2 in the airways of allergen-exposed mice induced expression of XBP1 and then TIM4 in DCs through a pathway involving the GEF Sos1 and the GTPase Ras. Targeting this pathway in DCs reduced the severity of experimentally induced allergic airway responses in mice, suggesting that these factors could be therapeutic targets for treating TH 2 cell–dependent inflammatory or allergic diseases. —John F. Foley [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF